CG
AST.WS

Cutler Group’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Cutler Group’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16
Closed – – 7463
2017
Q2 		$0 Hold
16
– – ﹤0.01% 7769
2017
Q1 		$0 Hold
16
– – ﹤0.01% 7968
2016
Q4 		$0 Hold
16
– – ﹤0.01% 8071
2016
Q3 		$0 Hold
16
– – ﹤0.01% 8063
2016
Q2 		$0 Buy
+16
New +$8 ﹤0.01% 7983

Cutler Group's AST.WS Position: Q3 2017 in Review

Cutler Group sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 16 shares.

Cutler Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Cutler Group reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 16 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Cutler Group first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Cutler Group's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.